SCHEMBL20072407

SCHEMBL20072407

Cc1cc(Cl)c2nc(-c3ccccn3)c([C@H](C)N)cc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.48
KDM4E B2RXH2 2/20 0.40
NPC1 O15118 2/20 0.40
MAPK14 Q16539 4/20 0.37
FFAR1 O14842 2/20 0.37
GRM5 P41594 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37
CBFB Q13951 1/20 0.36
MAPK1 P28482 1/20 0.36
CCR1 P32246 1/20 0.36
CCR5 P51681 1/20 0.36
CCR8 P51685 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
LIMK1 P53667 1/20 0.36
LIMK2 P53671 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16585318 0.85 PIK3CD (0.64) PIK3CDKDM4ENPC1MAPK14FFAR1
SCHEMBL1313525 0.85 PIK3CD (0.64) PIK3CDKDM4ENPC1MAPK14FFAR1
SCHEMBL20072410 0.80 PIK3CD (0.41) PIK3CDKDM4ENPC1MAPK14NPSR1
SCHEMBL20072403 0.77 PIK3CD (0.53) PIK3CD
SCHEMBL19344351 0.75 PIK3CD (0.47) PIK3CDKDM4ENPC1FFAR1CBFB
SCHEMBL22476054 0.75 PIK3CD (0.47) PIK3CDKDM4ENPC1FFAR1CBFB
SCHEMBL4178591 0.74 PIK3CD (0.44) PIK3CDKDM4ENPC1MAPK14FFAR1
SCHEMBL248096 0.72 KDM4E (0.42) PIK3CDKDM4ENPC1NPSR1RAB9A
SCHEMBL4178091 0.71 PIK3CD (0.46) PIK3CDCCR1CCR8
SCHEMBL248608 0.71 KDM4E (0.40) PIK3CDKDM4ENPC1CCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180105532-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180105532-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES MCL1, BCL9, MALT1 PIK3CD 16/4885KDM4E 1806/4885NPC1 4505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.